A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions
Read moreThe Department of Health and Social Care, the UK Health Security Agency and NHS England have jointly published the national flu vaccination programme letter today (25th May 2023) for the 2023/24 season. Eligible cohorts The letter confirms the eligible cohorts for the 2023/24 season and the vaccines which will be reimbursable under the Community Pharmacy
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled pens. MSN/2023/053 Tier 2 – medium impact Date of issue 24th May 2023 Tresiba® FlexTouch® (Insulin degludec) 100units/ml pens will be out of stock from August 2023 until January 2024. Tresiba
Read moreThe Royal Pharmaceutical Society (RPS) is conducting a consultation on the update of the professional standards for error reporting and are looking for views to ensure the standards are current, clear, relevant, and fit for purpose: The ‘Professional standards for the reporting, learning, sharing, taking action and review of incidents’ are being reviewed in collaboration
Read moreThe new, imposed NHS (Pharmaceutical and Local Pharmaceutical Services) (PLPS) Regulations 2013 come into force tomorrow, 25 May 2023, and introduce: a ‘notification’ procedure for 100-hour pharmacies to reduce their total weekly core opening hours to no less than 72 hours, subject to various requirements; a notification procedure for introducing or changing rest breaks, by
Read moreIt will soon be time for community pharmacy owners to verify their NHS Profile Manager profile information. Ahead of the 30th June 2023 deadline, we would like to remind members of the need for you to update NHS Profile Manager to ensure that your pharmacy’s NHS website and Directory of Services (DoS) profile information is kept up-to-date.
Read moreContractors (including head office staff) and community pharmacists have one month left to participate in an interview to share their views on the Quality Payments Scheme (QPS) (the previous name for the Pharmacy Quality Scheme (PQS)) and the PQS. ICF (an independent research consultancy) and the University of Manchester are carrying out the evaluation. The
Read moreThe Department of Health and Social Care (DHSC) has today (24/05/2023) granted the following list of price concessions for May 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.42 Amoxicillin 250mg/5ml oral suspension sugar free 100 £3.50 Atorvastatin 20mg tablets 28 £1.56 Bimatoprost 100micrograms/ml eye drops 3 £3.99 Clarithromycin 250mg/5ml oral
Read moreClass 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) Drug alert number: EL (23)A/19 Date issued: 23 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Metronidazole 200 mg/5 ml Oral Suspension, PL 30684/0236 Batch No
Read moreClass 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date
Read more
